Obesity

A new weight loss device, AspireAssist, offers a novel approach to cutting calories: draining them from the stomach before they are fully digested. The AspireAssist® system consists of a thin tube implanted in the stomach, connecting to an outside port on the skin of the belly.

New guidelines cite effectiveness, cost efficiency, and safety as reasons to consider procedure.

A recent study published in Obesity in May 2016 reported very discouraging findings for a group of participants who had lost weight on “The Biggest Loser” (TBL) reality TV show: not only did almost all of them regain a significant amount of weight over the 6-year period following the show, but they also had lower resting metabolic rates than expected for their body weights, even six years later. With the way the media ran with this story, it will not be a surprise if everyone just gives up staying thinner and blames excess weight on a faulty, and unchangeable, metabolism.

In study, 40 percent of adults with type 2 diabetes achieved a fasting glucose level of less than 126mg/dL.(7mmol/L) after eight weeks on a very low-calorie diet.

According to a new study, one more disease is associated with diabetes: twin study suggests genetic link between obesity, psoriasis and diabetes.

Study finds birth of younger sibling between 9 and 54 months decreases obesity odds for older sibling.

A woman, 72 years of age, type 2 diabetes, obesity, taking metformin, GLP1, ARB, and antidepressant (SSRI). Lost 20% total body weight in the past year. Recently complaining of dizziness and weakness. Glucose levels in the 60’s at home, at which time had symptoms of hypoglycemia. Glucose-lowering medications (metformin and GLP-1) were stopped. Continued to complain of dizziness and weakness especially in the morning.

Study finds remission rates of diabetes in patients who undergo weight loss procedure.

Endoscopic sleeve gastroplasty may be the answer to the obesity epidemic.

Surgery could lower patients' development of future medical issues.